Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-461-0 | CAS number: 1860-26-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Assessment of the Toxicokinetic Behaviour
There are no studies available in which the toxicokinetic properties of 2-ethyl-N,N-bis(2-ethylhexyl)hexylamine were investigated.
2-ethyl-N,N-bis(2-ethylhexyl)hexylamine (molecular weight of 353.7 g/mol) is a colourless to yellow liquid with low water solubility (calculated water solubility for the uncharged molecule: 0.00013 mg/L at 25 °C ; and for the charged molecule: 0.1031 mg/L at 25 °C (EPISUITE, see chapter “water solubility”). The log Pow for the uncharged molecule was calculated to be 10.13 at 25 °C (EPISUITE, see chapter “partition coefficient”), indicating that accumulation of the substance is possible.
Absorption
In an acute oral toxicity study, rats were administered the substance by gavage at a limit dose of 8170 mg/kg bw. No mortality, clinical signs and pathologic abnormalities were reported; therefore no conclusions concerning bioavailability of the substance after oral administration can be drawn from this study (BASF AG 1975, see chapter “acute oral toxicity”).
No acute dermal toxicity study is available. Based on a water solubility below 1 mg/L, dermal uptake is likely to be low. In addition, for highly lipophilic substances (log Pow greater than 6) that come into contact with the skin, the rate of transfer between the stratum corneum and the epidermis will be slow and will limit absorption across the skin. Uptake into the stratum corneum itself may be slow. Dermal uptake for such substances is expected to be low (ECHA GD 7c, 2008).
2-ethyl-N,N-bis(2-ethylhexyl)hexylamine has a very low measured vapour pressure of 0.00078 Pa at 20 °C (BASF AG 1986, see chapter “vapour pressure”); accordingly, in an inhalation hazard test of the dissolved substance with saturated vapour atmosphere, none of the 12 tested rats showed clinical signs indicative for systemic availability after inhalative exposure.
In addition, a Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test according to OECD TG 422 (GLP conform, 2010) and a subchronic repeated dose toxicity study according to OECD TG 408 (GLP conform, 2014) was performed with the substance in Wistar rats (see chapter “repeated dose toxicity”). In these studies the substance was administered in the diet and no NOAEL for general, systemic toxicity of the test substance could be determined for the F0 parental animals based on clinical-pathological and histopathological findings in all treated groups, predominantly dose-related histiocytic/mixed cell infiltrates in multiple organs which lead to secondary multiple local inflammatory reactions. Thus, bioavailability of the substance after oral administration is indicated.
Metabolism
Using the OECD toolbox vs.2.0, the (improved) liver metabolism simulator provided 50, and the skin simulator 19 potential metabolites (OECD toolbox vs.2.0, 2011).
Most of the predicted metabolites were hydroxylated aliphatic tertiary amines. Two of the liver metabolites and five of the skin metabolites were predicted by OASIS to be direct acting mutagens. These metabolites were aldehydes which may possibly act as direct acting Schiff Base formers. This prediction is not supported by various experimental studies on genetic toxicity. Studies on genotoxicity, i.e. ames assay, gene mutation in mammalian cells in-vitro, chromosome aberration assay in-vitro, gave no indications of a reactivity of the substance or its metabolites under the test conditions (i.e. no increased mutagenicity or cytotoxicity in treatments with or without metabolic activation).
Excretion
The potential hydroxylated metabolites as well as the parent chemical have a molecular weight lower than 500 g/mol. The potential metabolites are expected to be soluble in water and therefore are likely to be excreted predominantly via the urine (ECHA GD 7c, 2008).
Literature
ECHA (2008). GD 7c. Endpoint specific Guidance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.